Evidence map›Paper›PMID 26853346›Full record

ReviewInternational journal of radiation oncology, biology, physics2016

Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.

Thomas J FitzGerald, Maryann Bishop-Jodoin, David S Followill, James Galvin, Michael V Knopp, Jeff M Michalski, Mark A Rosen, Jeffrey D Bradley, Lalitha K Shankar, Fran Laurie and 6 more

Abstract readReview
In one paragraph

Review in International journal of radiation oncology, biology, physics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Quality assurance in radiation oncology.Pediatric blood & cancer · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Thomas J FitzGeraldImaging and Radiation Oncology Core Rhode Island, University of Massachusetts Memorial Medical Center, University of Massachusetts Medical School, Worcester, Massachusetts. Electronic address: Thomas.Fitzgerald@umassmed.edu.
Maryann Bishop-JodoinImaging and Radiation Oncology Core Rhode Island, University of Massachusetts Medical School, Worcester, Massachusetts.
David S FollowillImaging and Radiation Oncology Core Houston, University of Texas MD Anderson Cancer Center, Houston, Texas.
James GalvinImaging and Radiation Oncology Core Philadelphia, Thomas Jefferson University, Philadelphia, Pennsylvania.
Michael V KnoppImaging and Radiation Oncology Core Ohio, Wexner Medical Center, Ohio State University, Columbus, Ohio.
Jeff M MichalskiImaging and Radiation Oncology Core St. Louis, Washington University School of Medicine, St. Louis, Missouri.
Mark A RosenImaging and Radiation Oncology Core Philadelphia, University of Pennsylvania Health System, Philadelphia, Pennsylvania.
Jeffrey D BradleyWashington University School of Medicine-Radiation Oncology, St. Louis, Missouri.
Lalitha K ShankarNational Cancer Institute, Clinical Radiation Oncology Branch, Rockville, Maryland.
Fran LaurieImaging and Radiation Oncology Core Rhode Island, University of Massachusetts Medical School, Worcester, Massachusetts.
M Giulia CicchettiImaging and Radiation Oncology Core Rhode Island, University of Massachusetts Memorial Medical Center, University of Massachusetts Medical School, Worcester, Massachusetts.
Janaki MoniImaging and Radiation Oncology Core Rhode Island, University of Massachusetts Memorial Medical Center, University of Massachusetts Medical School, Worcester, Massachusetts.
C Norman ColemanNational Cancer Institute, Clinical Radiation Oncology Branch, Rockville, Maryland.
James A DeyeNational Cancer Institute, Clinical Radiation Oncology Branch, Rockville, Maryland.
Jacek CapalaNational Cancer Institute, Clinical Radiation Oncology Branch, Rockville, Maryland.
Bhadrasain VikramNational Cancer Institute, Clinical Radiation Oncology Branch, Rockville, Maryland.

Funding

IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
Radiation-induced molecular targetsZIABC010670 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI COLEMAN, NORMAN · 2009 to 2024
$17.3M
NCI NIH HHS CI U24 CA180803NCI NIH HHS U24 CA180803
6 · The paper itself

Abstract

Cancer treatment evolves through oncology clinical trials. Cancer trials are multimodal and complex. Assuring high-quality data are available to answer not only study objectives but also questions not anticipated at study initiation is the role of quality assurance. The National Cancer Institute reorganized its cancer clinical trials program in 2014. The National Clinical Trials Network (NCTN) was formed and within it was established a Diagnostic Imaging and Radiation Therapy Quality Assurance Organization. This organization is Imaging and Radiation Oncology Core, the Imaging and Radiation Oncology Core Group, consisting of 6 quality assurance centers that provide imaging and radiation therapy quality assurance for the NCTN. Sophisticated imaging is used for cancer diagnosis, treatment, and management as well as for image-driven technologies to plan and execute radiation treatment. Integration of imaging and radiation oncology data acquisition, review, management, and archive strategies are essential for trial compliance and future research. Lessons learned from previous trials are and provide evidence to support diagnostic imaging and radiation therapy data acquisition in NCTN trials.

Indexed as

Quality Assurance, Health CareBreast NeoplasmsChildClinical Trials as TopicData CollectionDiagnostic ImagingFemaleHodgkin DiseaseHumansLung NeoplasmsNational Cancer Institute (U.S.)NeoplasmsPrecision MedicineUnited States

Identifiers

PMID26853346
PMCPMC4746496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.